EURACTIV - In its last stretch, the Belgian Presidency of the Council of the EU is discussing regulatory data protection (RDP) for medicinal products. The goal is to balance pharmaceutical innovation with timely patient access across the EU. Read more

EURACTIV - Belgium and the Netherlands are pushing for a need-driven research model prioritising society's requirements, with an on emphasis addressing unmet medical needs. Belgium is setting the stage for future presidencies, with the Netherlands providing research insights. Read more

EURACTIV - Europe's pipeline of new antibiotics to tackle the growing antimicrobial resistance (AMR) crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives. Read more

EURACTIV - Prioritising pollution prevention or human health? That's the question probing the ethical limits of Belgium's pharmaceutical industry, amidst discussion of whether to approve new medicines if environmental risk assessments prove inadequate. Read more

EURACTIV - The Belgian innovative pharmaceutical industry continues to grow, but competitiveness dynamics and EU pharma package revisions are causing uncertainty. Euractiv spoke in depth with Caroline Ven, CEO of pharma.be, about the sector's concerns. Read more

EURACTIV - Tech leaders are warning that Europe faces a tech skills shortfall. Estimates indicate only 12 million skilled professionals may be available, despite EU targets of employing 20 million ICT specialists by 2030. Read more

EURACTIV - Europe must boost its investment in R&D, skills, infrastructure, and the integration of eco-friendly and advanced technologies if it is to achieve its environmental objectives and maintain a competitive edge, say institutional banks. Read more

EURACTIV - The Belgian Presidency is gearing up to tackle the escalating issue of medicine shortages across Europe. Experts call for enhanced collaboration, solidarity, and transparency to combat this crisis effectively. Read more

EURACTIV - Patients with rare diseases will be clear beneficiaries of the European Parliament's vote on the revised pharmaceutical legislation, says Belgian MEP Frédérique Ries. The pharma package revisions will also embed a European solidarity mechanism, capitalising on European added value. Read more

EURACTIV - Despite its significant potential, Europe trails North America and the Asian Pacific in Advanced Therapy Medicinal Product (ATMP) development, clinical trials, and investment. Belgium however, boasts one of the highest densities of advanced therapy companies globally. Read more